» Articles » PMID: 35920770

Differences in Symptom Experience Among Patients with Systemic Sclerosis: a Cluster Analytic Approach to Identifying Subgroups

Overview
Specialty Rheumatology
Date 2022 Aug 3
PMID 35920770
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Symptoms of people who have SSc are heterogeneous and difficult to address clinically. Because diverse symptoms often co-occur and may share common underlying mechanisms, identifying symptoms that cluster together may better target treatment approaches. We sought to identify and characterize patient subgroups based on symptom experience.

Methods: An exploratory hierarchical agglomerative cluster analysis was conducted to identify subgroups from a large SSc cohort from a single US academic medical centre. Patient-reported symptoms of pain interference, fatigue, sleep disturbance, dyspnoea, depression and anxiety were used for clustering. A multivariate analysis of variance (MANOVA) was used to examine the relative contribution of each variable across subgroups. Analyses of variance were performed to determine participant characteristics based on subgroup assignment. Presence of symptom clusters were tallied within subgroup.

Results: Participants (n = 587; 84% female, 41% diffuse cutaneous subtype, 59% early disease) divided into three subgroups via cluster analysis based on symptom severity: (i) no/minimal, (ii) mild, and (iii) moderate. Participants in mild and moderate symptoms subgroups had similar disease severity, but different symptom presentation. In the mild symptoms subgroup, pain, fatigue and sleep disturbance was the main symptom cluster. Participants in the moderate symptoms subgroup were characterized by co-occurring pain, fatigue, sleep disturbance, depression and anxiety.

Conclusion: Identification of distinct symptom clusters, particularly among SSc patients who experience mild and moderate symptoms, suggests potential differences in treatment approach and in mechanisms underlying symptom experience that require further study.

Citing Articles

Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis.

De Angelis R, Cipolletta E, Francioso F, Carotti M, Farah S, Giovagnoni A J Pers Med. 2024; 14(6).

PMID: 38929856 PMC: 11205232. DOI: 10.3390/jpm14060635.


Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.

Dai M, Zhang C, Li C, Wang Q, Gao C, Yue R Arthritis Res Ther. 2023; 25(1):155.

PMID: 37612772 PMC: 10463535. DOI: 10.1186/s13075-023-03139-y.


Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study.

Wojeck R, Knisely M, Bailey D, Somers T, Kwakkenbos L, Carrier M EClinicalMedicine. 2023; 62:102104.

PMID: 37533421 PMC: 10393558. DOI: 10.1016/j.eclinm.2023.102104.

References
1.
Kallen M, Mayes M, Kriseman Y, de Achaval S, Cox V, Suarez-Almazor M . The symptom burden index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol. 2010; 37(8):1692-8. PMC: 3887547. DOI: 10.3899/jrheum.090504. View

2.
Hinchcliff M, Beaumont J, Thavarajah K, Varga J, Chung A, Podlusky S . Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res (Hoboken). 2011; 63(11):1620-8. PMC: 3205420. DOI: 10.1002/acr.20591. View

3.
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S . The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010; 63(11):1179-94. PMC: 2965562. DOI: 10.1016/j.jclinepi.2010.04.011. View

4.
Lenz E, Pugh L, Milligan R, Gift A, Suppe F . The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997; 19(3):14-27. DOI: 10.1097/00012272-199703000-00003. View

5.
Kim H, McGuire D, Tulman L, Barsevick A . Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005; 28(4):270-82. DOI: 10.1097/00002820-200507000-00005. View